Comments
Shares of Piramal Enterprises and Pfizer will remain in focus following the Competition Commission of India approving the former’s proposed acquisition of four brands from the latter. In May, Piramal Enterprises had entered into a deal with Pfizer to acquire Ferradol, Neko, Sloan’s and Waterbury’s Compound brands for ₹110 crore. The deal also included trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.